84 Participants Needed

Digital Navigation for Type 2 Diabetes

JA
Overseen ByJorge A Rodriguez, MD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Brigham and Women's Hospital
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment Digital Navigation for Type 2 Diabetes?

Research shows that digital tools and training can help people with type 2 diabetes manage their condition better. Studies found that digital literacy training and patient portal use improve self-management and engagement in health activities, which are key components of the Digital Navigation treatment.12345

Is Digital Navigation for Type 2 Diabetes safe for humans?

The research articles reviewed do not provide specific safety data for Digital Navigation or related terms like Digital Literacy Training, Patient Portal Navigation, or Telehealth Navigation. However, they highlight general safety concerns related to electronic health records and patient data management, which can impact patient safety if not properly managed.678910

How is the Digital Navigation treatment for Type 2 Diabetes different from other treatments?

Digital Navigation for Type 2 Diabetes is unique because it focuses on improving patients' digital literacy and navigation skills to access and manage their health information online, unlike traditional treatments that may not emphasize digital skills. This approach helps patients better utilize digital health resources and telehealth services, potentially enhancing their self-management and education about diabetes.511121314

What is the purpose of this trial?

The goal of this clinical trial is to learn about digital literacy training in adult, Latino patient with type II diabetes. The main question it aims to answer is: Can providing digital literacy training during a hospital admission can help patients with their after-hospital care by using the patient portal and telehealth? Participants will receive digital literacy training by a digital navigator that focuses on the main patient portal functions. Researchers will compare patients who receive digital literacy training to those who receive standard of care (educational sheet) to see if it impacts their use of the patient portal after discharge.

Eligibility Criteria

This trial is for self-identified Latino adults with type II diabetes, admitted to Brigham and Women's Hospital, who speak English or Spanish. It excludes those critically ill or with dementia/delirium that affects learning and consent.

Inclusion Criteria

Preferred language: English or Spanish
I am a Latino adult with type II diabetes.
Admitted to general medicine floors at Brigham and Women's Hospital

Exclusion Criteria

Critical illness
I do not have dementia or similar conditions that affect my understanding.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive digital literacy training by a digital navigator focusing on patient portal functions

During hospital admission
1 visit (in-person)

Follow-up

Participants are monitored for their use of the patient portal and telehealth post-discharge

4 weeks

Treatment Details

Interventions

  • Digital Navigation
Trial Overview The study tests if digital literacy training by a navigator helps Latino patients use online health tools post-hospitalization. It compares the effectiveness of this training against standard educational materials.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Digital NavigationExperimental Treatment1 Intervention
Patients in this arm will receive 1:1 digital navigation support which will teach them about the functions of the patient portal and telehealth.
Group II: Standard of CareActive Control1 Intervention
Patients in this arm will receive the standard of care which will be an educational sheet.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Brigham and Women's Hospital

Lead Sponsor

Trials
1,694
Recruited
14,790,000+

National Institute on Minority Health and Health Disparities (NIMHD)

Collaborator

Trials
473
Recruited
1,374,000+

Findings from Research

The My Diabetes Care (MDC) portal was rated as having above-average usability by participants, with a median System Usability Scale score of 78.8, indicating it is user-friendly for individuals managing diabetes.
Participants, including those with limited health literacy, reported improved understanding of their diabetes health data and increased patient activation after using MDC, suggesting it could effectively support diabetes self-management.
The My Diabetes Care Patient Portal Intervention: Usability and Pre-Post Assessment.Martinez, W., Hackstadt, AJ., Hickson, GB., et al.[2022]
A survey of 848 Spanish nurses revealed that most believe reliable digital information can help reduce unnecessary patient consultations and that over half of their patients could benefit from online health resources.
Nurses identified older age and low educational levels of patients as major barriers to using digital tools, while training and user-friendly technology were seen as key enablers to enhance patient empowerment in health education.
Nurses' view of benefits, enablers and constraints to the use of digital health tools with patients: A cross-sectional study.Navarro Martínez, O., Igual García, J., Salcedo, VT.[2023]
In a pilot program involving 28 participants with type 2 diabetes, digital literacy was found to be essential for effective self-management using mobile health (mHealth) tools.
Providing digital training and support significantly improved participants' engagement and sustainable use of mHealth applications, highlighting the importance of equipping patients with the necessary skills to manage their health effectively.
The Role of Digital Engagement in the Self-Management of Type 2 Diabetes.Park, S., Burford, S., Nolan, C., et al.[2018]

References

The My Diabetes Care Patient Portal Intervention: Usability and Pre-Post Assessment. [2022]
Nurses' view of benefits, enablers and constraints to the use of digital health tools with patients: A cross-sectional study. [2023]
The Role of Digital Engagement in the Self-Management of Type 2 Diabetes. [2018]
The impact of electronic education on metabolic control indicators in patients with diabetes who need insulin: a randomised clinical control trial. [2022]
Can digital health apps provide patients with support to promote structured diabetes education and ongoing self-management? A real-world evaluation of myDiabetes usage. [2023]
Development and Usability Testing of a System to Detect Adverse Events and Medical Mistakes. [2023]
Register-Based Research of Adverse Events Revealing Incomplete Records Threatening Patient Safety. [2020]
Novel augmented reality solution for improving health literacy around antihypertensives in people living with type 2 diabetes mellitus: protocol of a technology evaluation study. [2019]
Identifying Electronic Health Record Usability And Safety Challenges In Pediatric Settings. [2019]
The Challenges of Electronic Health Records and Diabetes Electronic Prescribing: Implications for Safety Net Care for Diverse Populations. [2021]
Consumer Use of "Dr Google": A Survey on Health Information-Seeking Behaviors and Navigational Needs. [2022]
12.United Statespubmed.ncbi.nlm.nih.gov
Getting a technology-based diabetes intervention ready for prime time: a review of usability testing studies. [2021]
Cocreation of Massive Open Online Courses to Improve Digital Health Literacy in Diabetes: Pilot Mixed Methods Study. [2022]
"Fala-M@no-COVID-19": technological development of a health navigation program for men during the pandemic. [2023]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security